Shield Therapeutics Share Discussion Threads

[babbler] 28/9/2023 14:13

Heard not heart.

[babbler] 28/9/2023 14:13

Your voice will be heart... it will be filed under "we couldn't care less". FCA do nada.

[tripletop1] 28/9/2023 14:07

i bet you GM and HP are really looking forward the Investor Meet lol

[qipincha] 28/9/2023 13:32

anyone know how to attend the meeting today?

[husbod] 28/9/2023 13:26

Bought some more at that price. Really not worth partaking in the retail offer.Look on the bright side of life - if it goes back up to 10p you've made 25%

[arab3] 28/9/2023 13:24

i think you may do better than that parob

[arab3] 28/9/2023 13:23

i dont think your thoughts count for anything patt ,

[parob] 28/9/2023 13:23

Buying at 7.75p

[eeza] 28/9/2023 13:21

Off 20% - a re-run of yesterday.

[rodney101] 28/9/2023 13:17

4 years of past record screaming out Yes Definitely there is no gold at the end of STX rainbow.

[eeza] 28/9/2023 13:15

"Every fund raise is painful."


Not for the placees, who have forward sold their allocation. Bribes, which have been taken from s/hlder's pockets.

[rodney101] 28/9/2023 13:12

Yes this THE last placing lolReading through your posts on bens thread I really thought you was a logical man but turns out I was wrong Who in there right mind would invest money in a company with a track record like stx

[purchaseatthetop] 28/9/2023 13:07

Personally I think that is the last fund raise. Everyfund raise is painful.

[rodney101] 28/9/2023 13:06

How much more proof one needs Management of this company like most of AIM listed companies done nothing but destroy shareholder value Shocking destruction of value here

[hamidahamida] 28/9/2023 12:59

Tuesday 30th July 2019 Shares were at 190p4years later after multiple deeply discounted placings with jam tomorrow targets, today share price trading at 8p.Proof is in the pudding this company, past record says this company is unable to deliver what it promises other than placings after placings..So Get Out whilst you can there is No Gold at the end of this rainbow.

[qipincha] 28/9/2023 12:53

hope the company will not do this stupid offer with such a low price any more!

[qipincha] 28/9/2023 12:53

Successful completion of US$ 6.1m (GBP5.0m) Equity Fundraise

London, UK - 28 September 2023: Shield Therapeutics plc (LSE: STX ), a commercial stage pharmaceutical company , is pleased to announce the successful completion of the subscription (the "Subscription") and placing (the "Placing") which were announced earlier today. The Subscription and Placing have raised aggregate gross proceeds of c. US$ 6.1 m (c. GBP 5.0 m). A total of 62,393,060 new ordinary shares to be allotted pursuant to the Subscription and the Placing are to be issued at an issue price of 8.0 pence per share (the "Issue Price"). The Company also announced, earlier today, details of a retail offer to raise up to an additional c. US$1.4m (c. GBP 1.14 m) (the "Retail Offer", and together with the Placing and the Subscription, the "Equity Fundraising").

Pursuant to the Placing a total of 41,380,508 new ordinary shares in the Company at the Issue Price (the "Placing Shares") have been conditionally placed by Peel Hunt LLP ("Peel Hunt") and Cavendish Capital Markets Ltd ("Cavendish") with new and existing investors at the Issue Price.

Pursuant to the Subscription, AOP Health International Management AG ("AOP"), a major shareholder in the Company, has conditionally subscribed for a total of 21,012,552 new ordinary shares in the Company at the Issue Price (the "Subscription Shares" and, together with the Placing Shares, and the Retail Offer Shares, the "New Shares"). The Placing Shares and the Subscription Shares represent 8.0 per cent. of the existing issued ordinary share capital of the Company. The Issue Price represents a discount of 17.9 per cent. to the closing price of 9.75 pence on 27 September 2023. Up to a further 14,260,720 new ordinary shares in the Company may be issued pursuant to the Retail Offer (the "Retail Offer Shares"). No part of the Equity Fundraising is underwritten.

Additionally, pursuant to the exercise of all of its outstanding warrants with an exercise price of 6.75p per warrant, AOP has subscribed for a further 5,147,754 new ordinary shares (the "AOP Warrant Shares") for an aggregate exercise price of GBP347,473.40 conditional on the admission of (i) the New Shares, and (ii) such number of Retail Offer Shares to be issued pursuant to the REX Retail Offer, to trading on AIM becoming effective by means of the issue by London Stock Exchange plc (the "London Stock Exchange") of a dealing notice under Rule 6 of the AIM Rules.

The New Shares and the AOP Warrant Shares will, when issued, be fully paid and will be issued subject to the Company's articles of association and will rank pari passu in all respects with the existing issued ordinary shares in the capital of the Company, including the right to receive all dividends and other distributions declared, made or paid on or in respect of such shares by reference to a record date falling after their issue.

Application has been made to the London Stock Exchange for the New Shares and the AOP Warrant Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 08.00 a.m. on or around 4 October 2023 (or such later date as the Company, Peel Hunt and Cavendish may agree, being no later than 8.00 a.m. on 13 October 2 023 ).

The Retail Offer through the REX platform is expected to remain open until 10:00 a.m. on 3 October 2023. A further announcement will be made in relation to the result of the Retail Offer.

[parob] 28/9/2023 12:49

Yep limited downside risk for newbies at this price yet decent upside potential, although will take a while to churn the shares but nowhere near as long as the past placing.

[arab3] 28/9/2023 12:42

why do they all list here and not in the USA ?

[ekcs] 28/9/2023 12:32

...Except for the recurring dilution (albeit this is a small one compared to previous and the price reaction is somewhat overdone but it is always going to drop back to the issue price ) which goes straight to value dilution. Always has, always will. That said they've put their collective necks on the block this time with the various targets and q on q growth seems promising.

[qipincha] 28/9/2023 12:18

although I am not happy about the sudden drop, the need of extra funding was implied in previous news when they talked about listed on US...

[kop202] 28/9/2023 12:16

..... the AOP comment?

[reviewwworld] 28/9/2023 12:11

Nothing mystic about it. The company have literally stated that in their release this morning for Christ's sake !!